CRISPR Therapeutics-Aktie Intraday-Chart

Chart

CRISPR Therapeutics-Aktie 1-Wochen-Chart

Chart
Performance:  13,53%  |  5,91 EUR

CRISPR Therapeutics-Aktie 2-Wochen-Chart

Chart
Performance:  16,16%  |  6,90 EUR

CRISPR Therapeutics-Aktie 1-Monats-Chart

Chart
Performance:  19,23%  |  8,00 EUR

CRISPR Therapeutics-Aktie 6-Monats-Chart

Chart
Performance:  -16,29%  |  -9,65 EUR

CRISPR Therapeutics-Aktie 12-Monats-Chart

Chart
Performance:  49,40%  |  16,40 EUR

CRISPR Therapeutics-Aktie 36-Monats-Chart

Chart
Performance:  2,69%  |  1,30 EUR

CRISPR Therapeutics-Aktie 48-Monats-Chart

Chart
Performance:  -13,36%  |  -7,65 EUR

CRISPR Therapeutics-Aktie 5-Jahres-Chart

Chart
Performance:  -49,90%  |  -49,40 EUR

CRISPR Therapeutics-Aktie 10-Jahres-Chart

Chart

CRISPR Therapeutics-Aktie Langfrist-Chart

Chart

Unsere Mission